期刊
PLANT METHODS
卷 18, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13007-022-00870-6
关键词
Citrus; Protoplast; CRISPR; Cas9; Genome editing; Lipofection; Systemic acquired resistance (SAR); NPR3
资金
- Specialty Crop Research Initiative (SCRI) Citrus Disease Research and Extension Program (CDRE) [FLA-MCS-005676]
Through the CRISPR/Cas9 system and genome editing techniques on protoplasts, we successfully integrated exogenous DNA fragments into the citrus plant genome and achieved gene editing in citrus plants by regulating the expression of the negative regulator CsNPR3 gene.
Background The genetic engineering of crops has enhanced productivity in the face of climate change and a growing global population by conferring desirable genetic traits, including the enhancement of biotic and abiotic stress tolerance, to improve agriculture. The clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) system has been found to be a promising technology for genomic editing. Protoplasts are often utilized for the development of genetically modified plants through in vitro integration of a recombinant DNA fragment into the plant genome. We targeted the citrus Nonexpressor of Pathogenesis-Related 3 (CsNPR3) gene, a negative regulator of systemic acquired resistance (SAR) that governs the proteasome-mediated degradation of NPR1 and developed a genome editing technique targeting citrus protoplast DNA to produce stable genome-edited citrus plants. Results Here, we determined the best cationic lipid nanoparticles to deliver donor DNA and described a protocol using Lipofectamine (TM) LTX Reagent with PLUS Reagent to mediate DNA delivery into citrus protoplasts. A Cas9 construct containing a gRNA targeting the CsNPR3 gene was transfected into citrus protoplasts using the cationic lipid transfection agent Lipofectamine with or without polyethylene glycol (PEG, MW 6000). The optimal transfection efficiency for the encapsulation was 30% in Lipofectamine, 51% in Lipofectamine with PEG, and 2% with PEG only. Additionally, plasmid encapsulation in Lipofectamine resulted in the highest cell viability percentage (45%) compared with PEG. Nine edited plants were obtained and identified based on the T7EI assay and Sanger sequencing. The developed edited lines exhibited downregulation of CsNPR3 expression and upregulation of CsPR1. Conclusions Our results demonstrate that utilization of the cationic lipid-based transfection agent Lipofectamine is a viable option for the successful delivery of donor DNA and subsequent successful genome editing in citrus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据